222 related articles for article (PubMed ID: 11106609)
1. Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells.
Grant AO; Chandra R; Keller C; Carboni M; Starmer CF
Biophys J; 2000 Dec; 79(6):3019-35. PubMed ID: 11106609
[TBL] [Abstract][Full Text] [Related]
2. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
Wang GK; Russell C; Wang SY
J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091
[TBL] [Abstract][Full Text] [Related]
3. Blockade of cardiac sodium channels. Competition between the permeant ion and antiarrhythmic drugs.
Barber MJ; Wendt DJ; Starmer CF; Grant AO
J Clin Invest; 1992 Aug; 90(2):368-81. PubMed ID: 1322937
[TBL] [Abstract][Full Text] [Related]
4. Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues.
Liu H; Atkins J; Kass RS
J Gen Physiol; 2003 Mar; 121(3):199-214. PubMed ID: 12601084
[TBL] [Abstract][Full Text] [Related]
5. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
6. Frequency-independent blockade of cardiac Na+ channels by riluzole: comparison with established anticonvulsants and class I anti-arrhythmics.
Mestre M; Djellas Y; Carriot T; Cavero I
Fundam Clin Pharmacol; 2000; 14(2):107-17. PubMed ID: 10796057
[TBL] [Abstract][Full Text] [Related]
7. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
[TBL] [Abstract][Full Text] [Related]
8. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
Sheets MF; Hanck DA
J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
[TBL] [Abstract][Full Text] [Related]
9. Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide.
Nagatomo T; January CT; Makielski JC
Mol Pharmacol; 2000 Jan; 57(1):101-7. PubMed ID: 10617684
[TBL] [Abstract][Full Text] [Related]
10. Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome.
Abriel H; Wehrens XH; Benhorin J; Kerem B; Kass RS
Circulation; 2000 Aug; 102(8):921-5. PubMed ID: 10952963
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic effects of sodium channel blockade on anisotropic conduction and conduction block in canine myocardium: preferential slowing of longitudinal conduction by flecainide versus disopyramide or lidocaine.
Kondo T; Yamaki M; Kubota I; Tachibana H; Tomoike H
J Am Coll Cardiol; 1997 Jun; 29(7):1639-44. PubMed ID: 9180130
[TBL] [Abstract][Full Text] [Related]
12. State-dependent trapping of flecainide in the cardiac sodium channel.
Ramos E; O'leary ME
J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of sodium channel blockers on guinea pig left atrium.
Shirayama T; Inoue D; Inoue M; Tatsumi T; Yamahara Y; Asayama J; Katsume H; Nakagawa M
J Pharmacol Exp Ther; 1991 Nov; 259(2):884-93. PubMed ID: 1658312
[TBL] [Abstract][Full Text] [Related]
14. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
15. Selective block of late currents in the DeltaKPQ Na(+) channel mutant by pilsicainide and lidocaine with distinct mechanisms.
Ono K; Kaku T; Makita N; Kitabatake A; Arita M
Mol Pharmacol; 2000 Feb; 57(2):392-400. PubMed ID: 10648650
[TBL] [Abstract][Full Text] [Related]
16. The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels.
Grant AO; John JE; Nesterenko VV; Starmer CF; Moorman JR
Mol Pharmacol; 1996 Dec; 50(6):1643-50. PubMed ID: 8967988
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of the anticholinergic effect of SUN 1165 in comparison with flecainide, disopyramide and quinidine in single atrial myocytes isolated from guinea-pig.
Inomata N; Ishihara T; Akaike N
Br J Pharmacol; 1991 Dec; 104(4):1007-11. PubMed ID: 1810589
[TBL] [Abstract][Full Text] [Related]
18. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles.
Kawamura T; Kodama I; Toyama J; Hayashi H; Saito H; Yamada K
Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934
[TBL] [Abstract][Full Text] [Related]
19. Quaternary ammonium block of mutant Na+ channels lacking inactivation: features of a transition-intermediate mechanism.
Kimbrough JT; Gingrich KJ
J Physiol; 2000 Nov; 529 Pt 1(Pt 1):93-106. PubMed ID: 11080254
[TBL] [Abstract][Full Text] [Related]
20. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
Ragsdale DS; Scheuer T; Catterall WA
Mol Pharmacol; 1991 Nov; 40(5):756-65. PubMed ID: 1658608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
